Financhill
Back

Alterity Therapeutics Stock Predictions

Alterity Therapeutics Stock Forecast

  • Is Alterity Therapeutics Stock Undervalued?
    The current Alterity Therapeutics [ATHE] share price is $1.07. The Score for ATHE is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ATHE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Alterity Therapeutics Stock Go Up Next Year?

Data Unavailable

Alterity Therapeutics Stock Rating

Data Unavailable

Alterity Therapeutics Stock Price History

Is ATHE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ATHE is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Australia
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alteritytherapeutics.com

52-Week Data

52-Week High:
5.41
52-Week Low:
1.00

Prediction Charts

Market Cap:
9.35M
Price in USD:
1.07
Volume:
38.15K
Beta:
0.92

Technical Analysis

SMA50:
1.22
SMA100:
1.37
SMA200:
1.66
52-Wk Change:
-35.54%

Stock Predictions

  • Is Alterity Therapeutics stock public?
    Yes, Alterity Therapeutics is a publicly traded company.
  • What is the Alterity Therapeutics stock quote today?
    The Alterity Therapeutics stock price is 1.07 USD today.
  • How to buy Alterity Therapeutics stock online?
    You can buy Alterity Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 1.18 1.18 1.19 1.17
Nov-6 1.24 1.22 1.24 1.19
Nov-7 1.18 1.18 1.19 1.14
Nov-8 1.23 1.16 1.23 1.14
Nov-11 1.16 1.19 1.19 1.14
Nov-12 1.14 1.16 1.18 1.14
Nov-13 1.27 1.18 1.27 1.16
Nov-14 1.29 1.17 1.29 1.15
Nov-15 1.24 1.11 1.24 1.10
Nov-18 1.09 1.10 1.12 1.08
Nov-19 1.09 1.12 1.13 1.09
Nov-20 1.10 1.05 1.11 1.05
Nov-21 1.09 1.07 1.10 1.07
Nov-22 1.09 1.07 1.11 1.00

Alterity Therapeutics Earnings

Data Unavailable

Alterity Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.00 per share.

* Alterity Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.